{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:59:52Z","timestamp":1790200792912,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Patients with end-stage liver disease and pretransplant <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> colonization are problematic for determining liver transplant candidacy and timing of transplantation because of concerns for posttransplant invasive aspergillosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We performed a retrospective review of the medical and laboratory records of all adult patients (aged \u226518 y) who underwent liver transplantation with pretransplant <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> colonization at the Ronald Reagan University of California, Los Angeles, Medical Center from January 1, 2010, to December 31, 2015.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A total of 27 patients who had <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> colonization (respiratory tract 26, biliary tract 1) before liver transplantation were identified. Pretransplant characteristics included previous liver transplant (11 of 27, 40.7%), dialysis (22 of 27, 81.5%), corticosteroid therapy (12 of 27, 44.4%), intensive care unit stay (27 of 27, 100%), and median model for end-stage liver disease score of 39. Only 22.2% (6 of 27) received pretransplant antifungal agents (median duration, 5 d), whereas 100% (27 of 27) received posttransplant antifungal prophylaxis (voriconazole 81.4%, 22 of 27; echinocandin 14.8%, 4 of 27; voriconazole plus echinocandin 3.7%, 1 of 27) for median duration of 85 d. Posttransplant invasive fungal infection occurred in 14.8% (4 of 27; aspergillosis 3, mucormycosis 1). Both 6-month and 12-month survival were 66.7% (18 of 27), but only 1 death was due to fungal infection. Other causes of death were liver graft failure, intraabdominal complications, and malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>A substantial number of patients with pretransplant <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> colonization can still undergo successful liver transplantation if they are otherwise suitable candidates and receive appropriate antifungal prophylaxis. Posttransplant outcome in these patients is determined mostly by noninfectious complications and not fungal infection. Pretransplant <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> colonization alone should not necessarily preclude or delay liver transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003276","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T05:16:08Z","timestamp":1587014168000},"page":"586-592","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Liver Transplantation in Patients With Pretransplant Aspergillus Colonization: Is It Safe to Proceed?"],"prefix":"10.1097","volume":"105","author":[{"given":"Arpit","family":"Amin","sequence":"first","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Molina","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Quach","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McMillan","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DiNorcia","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatche G.","family":"Agopian","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady M.","family":"Kaldas","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Farmer","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald W.","family":"Busuttil","sequence":"additional","affiliation":[{"name":"Division of Liver and Pancreas Transplantation, Department of Surgery, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew J.","family":"Winston","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients.","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","article-title":"Invasive aspergillosis in transplant recipients.","volume":"78","author":"Paterson","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/infdis\/166.6.1379","article-title":"Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation.","volume":"166","author":"Kusne","year":"1992","journal-title":"J Infect Dis"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for invasive fungal infections complicating orthotopic liver transplantation.","volume":"170","author":"Collins","year":"1994","journal-title":"J Infect Dis"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007890-199602270-00029","article-title":"Incidence and significance of Aspergillus cultures following liver and kidney transplantation.","volume":"61","author":"Brown","year":"1996","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SLA.0b013e3182a15db4","article-title":"The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.","volume":"258","author":"Agopian","year":"2013","journal-title":"Ann Surg"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12281-014-0207-9","article-title":"Aspergillosis in lung transplant patients: focus on colonization pre-transplant and impact on invasive disease.","volume":"8","author":"Gitman","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary.","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"e13630","DOI":"10.1111\/ctr.13630","article-title":"Antifungal prophylaxis in lung transplant: a survey of United States\u2019 transplant centers.","volume":"33","author":"Pennington","year":"2019","journal-title":"Clin Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/bmt.2015.237","article-title":"Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the infectious diseases and acute leukemia working parties.","volume":"51","author":"Penack","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bmt.2016.259","article-title":"Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.","volume":"52","author":"Maziarz","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3324\/haematol.2009.020073","article-title":"Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.","volume":"95","author":"Cordonnier","year":"2010","journal-title":"Haematologica"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e31829d674f","article-title":"Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.","volume":"96","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.00429-09","article-title":"Voriconazole pharmacokinetics in liver transplant recipients.","volume":"54","author":"Johnson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus universal antifungal prophylaxis among liver transplant recipients.","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am J Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/lt.24365","article-title":"Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.","volume":"22","author":"Balogh","year":"2016","journal-title":"Liver Transpl"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent.","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.transproceed.2004.09.043","article-title":"Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.","volume":"36","author":"Mathis","year":"2004","journal-title":"Transplant Proc"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbmt.2005.12.032","article-title":"Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.","volume":"12","author":"Marty","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00007890-198809000-00038","article-title":"Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy.","volume":"46","author":"Brems","year":"1988","journal-title":"Transplantation"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinids\/21.5.1077","article-title":"Infections in liver transplant recipients.","volume":"21","author":"Winston","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1097\/TP.0000000000000763","article-title":"Performance characteristics of galactomannan and \u03b2-d-glucan in high-risk liver transplant recipients.","volume":"99","author":"Singh","year":"2015","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:14:19Z","timestamp":1749064459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003276","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,13]]}}}